Jeremy Graff
Vermogen: 41 087 $ op 31-05-2026
Vermogen: 41 087 $ op 31-05-2026
Jeremy R.
Graff is currently Chairman at IN8bio, Inc. starting in 2026, Trustee at Wood Hudson Cancer Research Laboratory, Inc., and President & Chief Development Officer at Allarity Therapeutics, Inc. beginning in 2024.
Former roles include Chief Scientific Officer at IMV, Inc. from 2021 to 2024, Chief Development Officer & Senior VP-Research at HiberCell, Inc. from 2020 to 2021, and President & Chief Scientific Officer at Biothera Pharmaceuticals, Inc. (Delaware) from 2018 to 2020 as well as at Biothera, Inc. Education includes undergraduate studies at Thomas More University and a doctorate from the University of Kentucky.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 29-04-2026 | 24.881 ( 0,16% ) | 40 805 $ | 31-05-2026 | |
| 09-05-2026 | 151 ( 0% ) | 282 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| IN8BIO, INC. | Voorzitter | 28-02-2026 |
| ALLARITY THERAPEUTICS, INC. | President | 03-10-2024 |
Wood Hudson Cancer Research Laboratory, Inc.
Wood Hudson Cancer Research Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides scientific research services for cancer causes, diagnosis, treatment and prevention | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| IMV INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2024 |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops treatments to prevent cancer relapse and metastasis | Hoofd Techniek/Wetenschap/O&O | 01-03-2021 |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | President | 01-06-2020 |
Biothera Pharmaceuticals, Inc. (Delaware)
Biothera Pharmaceuticals, Inc. (Delaware) Medical/Nursing ServicesHealth Services Develops cancer immunotherapy | President | 01-06-2020 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 9 |
|---|---|
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | Commercial Services |
Thomas More University
Thomas More University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kentucky
University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IMV, Inc.
IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Biothera Pharmaceuticals, Inc. (Delaware)
Biothera Pharmaceuticals, Inc. (Delaware) Medical/Nursing ServicesHealth Services Develops cancer immunotherapy | Health Services |
IN8bio, Inc.
IN8bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer | Health Technology |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops treatments to prevent cancer relapse and metastasis | Commercial Services |
Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics | Health Technology |
Wood Hudson Cancer Research Laboratory, Inc.
Wood Hudson Cancer Research Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides scientific research services for cancer causes, diagnosis, treatment and prevention | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau